Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1CNS 1

Conditions

von Hippel-Lindau Disease 2Pheochromocytoma 2Paraganglioma 2Neuroectodermal Tumors, Primitive 1Hemangioblastoma 1Carcinoma, Renal Cell 1Adenoma, Islet Cell 1

Interventions

belzutifan 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangioblastoma × belzutifan × Endocrine × Clear all
NCT07167329 2025-09-11

BELIEVE-VHL

AC Camargo Cancer Center

Phase 2 Recruiting
100 enrolled
CNSEndocrineGenitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Paraganglioma, Pheochromocytoma, Neuroectodermal Tumors, Primitive, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡